ArticleScientific reports2026
Copper doped hybrid nanosponges functionalized with Aplysina aerophoba extract for enhanced bioactive performance.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, Cu (II) ion incorporated hybrid nanosponge (Cu2+ hNSs) derived from extracts of Aplysina aerophoba was synthesised, and its antimicrobial activity against some bacterial species, including Staphylococcus aureus, Aeromonas hydrophila, Aeromonas sobria, Escherichia coli, and Salmonella enterica, was evaluated. According to the results of the characterisation test, Cu(II)-incorporated hybrid nanosponges were well dispersed on the surface. The diameters of A. aerophoba extract and Cu(II) ion incorporated hybrid nanosponges were found to range between 12 and 14 μm using scanning electron microscopy (SEM) for obtaining SEM images. The antioxidant activity of A. aerophoba extract and Cu(II) ion incorporated hybrid nanosponge was determined against 2,2-diphenyl-1-picrylhydrazyl (DPPH). Cu(II) ion-incorporated hybrid nanosponges exhibit significantly higher antimicrobial activity against S. aureus, A. hydrophila, A. sobria, Escherichia coli, and S. enterica compared to the A. aerophoba extract, which alone showed minimal activity. As a result, we suggest that Cu (II) ion incorporated hybrid nanosponges were synthesized with A. aerophoba extract by an effective, inexpensive, and eco-friendly method and are applicable for antimicrobial activity studies. This study demonstrates the laboratory-scale feasibility of Cu(II)-doped hybrid nanosponges functionalized with Aplysina aerophoba extract, providing proof-of-concept results that may serve as a foundation for future commercial applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.